United States Somatostatin Market Report 2016

November 2016 | 112 pages | ID: UFA75E62A4BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Somatostatin

Revenue, means the sales value of Somatostatin

This report studies sales (consumption) of Somatostatin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Merck
• Sanofi
• Lyomark Pharma
• ALFA WASSERMANN
• Polypeptide Laboratories
• SAMARTH
• UBPL
• TianTaiShan
• Yangtze
• SIYAO
• ShuangCheng
• TianTaiShan
• Hainan Zhonghe
• SL PHARM
• Wuhan Hualon
• Qingdao Guoda
• Chengdu Shengnuo
• Longjin

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Somatostatin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Somatostatin Market Report 2016

1 SOMATOSTATIN OVERVIEW

1.1 Product Overview and Scope of Somatostatin
1.2 Classification of Somatostatin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Somatostatin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Somatostatin (2011-2021)
  1.4.1 United States Somatostatin Sales and Growth Rate (2011-2021)
  1.4.2 United States Somatostatin Revenue and Growth Rate (2011-2021)

2 UNITED STATES SOMATOSTATIN COMPETITION BY MANUFACTURERS

2.1 United States Somatostatin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Somatostatin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Somatostatin Average Price by Manufactures (2015 and 2016)
2.4 Somatostatin Market Competitive Situation and Trends
  2.4.1 Somatostatin Market Concentration Rate
  2.4.2 Somatostatin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES SOMATOSTATIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Somatostatin Sales and Market Share by Type (2011-2016)
3.2 United States Somatostatin Revenue and Market Share by Type (2011-2016)
3.3 United States Somatostatin Price by Type (2011-2016)
3.4 United States Somatostatin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES SOMATOSTATIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Somatostatin Sales and Market Share by Application (2011-2016)
4.2 United States Somatostatin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES SOMATOSTATIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Merck
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Somatostatin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Merck Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Sanofi
  5.2.2 Somatostatin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Sanofi Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Lyomark Pharma
  5.3.2 Somatostatin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Lyomark Pharma Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 ALFA WASSERMANN
  5.4.2 Somatostatin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 ALFA WASSERMANN Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Polypeptide Laboratories
  5.5.2 Somatostatin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Polypeptide Laboratories Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 SAMARTH
  5.6.2 Somatostatin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 SAMARTH Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 UBPL
  5.7.2 Somatostatin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 UBPL Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 TianTaiShan
  5.8.2 Somatostatin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 TianTaiShan Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Yangtze
  5.9.2 Somatostatin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Yangtze Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 SIYAO
  5.10.2 Somatostatin Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 SIYAO Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 ShuangCheng
5.12 TianTaiShan
5.13 Hainan Zhonghe
5.14 SL PHARM
5.15 Wuhan Hualon
5.16 Qingdao Guoda
5.17 Chengdu Shengnuo
5.18 Longjin

6 SOMATOSTATIN MANUFACTURING COST ANALYSIS

6.1 Somatostatin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Somatostatin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Somatostatin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Somatostatin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES SOMATOSTATIN MARKET FORECAST (2016-2021)

10.1 United States Somatostatin Sales, Revenue Forecast (2016-2021)
10.2 United States Somatostatin Sales Forecast by Type (2016-2021)
10.3 United States Somatostatin Sales Forecast by Application (2016-2021)
10.4 Somatostatin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Somatostatin
Table Classification of Somatostatin
Figure United States Sales Market Share of Somatostatin by Type in 2015
Table Application of Somatostatin
Figure United States Sales Market Share of Somatostatin by Application in 2015
Figure United States Somatostatin Sales and Growth Rate (2011-2021)
Figure United States Somatostatin Revenue and Growth Rate (2011-2021)
Table United States Somatostatin Sales of Key Manufacturers (2015 and 2016)
Table United States Somatostatin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Somatostatin Sales Share by Manufacturers
Figure 2016 Somatostatin Sales Share by Manufacturers
Table United States Somatostatin Revenue by Manufacturers (2015 and 2016)
Table United States Somatostatin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Somatostatin Revenue Share by Manufacturers
Table 2016 United States Somatostatin Revenue Share by Manufacturers
Table United States Market Somatostatin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Somatostatin Average Price of Key Manufacturers in 2015
Figure Somatostatin Market Share of Top 3 Manufacturers
Figure Somatostatin Market Share of Top 5 Manufacturers
Table United States Somatostatin Sales by Type (2011-2016)
Table United States Somatostatin Sales Share by Type (2011-2016)
Figure United States Somatostatin Sales Market Share by Type in 2015
Table United States Somatostatin Revenue and Market Share by Type (2011-2016)
Table United States Somatostatin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Somatostatin by Type (2011-2016)
Table United States Somatostatin Price by Type (2011-2016)
Figure United States Somatostatin Sales Growth Rate by Type (2011-2016)
Table United States Somatostatin Sales by Application (2011-2016)
Table United States Somatostatin Sales Market Share by Application (2011-2016)
Figure United States Somatostatin Sales Market Share by Application in 2015
Table United States Somatostatin Sales Growth Rate by Application (2011-2016)
Figure United States Somatostatin Sales Growth Rate by Application (2011-2016)
Table Merck Basic Information List
Table Merck Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Somatostatin Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Somatostatin Sales Market Share (2011-2016)
Table Lyomark Pharma Basic Information List
Table Lyomark Pharma Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lyomark Pharma Somatostatin Sales Market Share (2011-2016)
Table ALFA WASSERMANN Basic Information List
Table ALFA WASSERMANN Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table ALFA WASSERMANN Somatostatin Sales Market Share (2011-2016)
Table Polypeptide Laboratories Basic Information List
Table Polypeptide Laboratories Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Polypeptide Laboratories Somatostatin Sales Market Share (2011-2016)
Table SAMARTH Basic Information List
Table SAMARTH Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table SAMARTH Somatostatin Sales Market Share (2011-2016)
Table UBPL Basic Information List
Table UBPL Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table UBPL Somatostatin Sales Market Share (2011-2016)
Table TianTaiShan Basic Information List
Table TianTaiShan Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table TianTaiShan Somatostatin Sales Market Share (2011-2016)
Table Yangtze Basic Information List
Table Yangtze Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Yangtze Somatostatin Sales Market Share (2011-2016)
Table SIYAO Basic Information List
Table SIYAO Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table SIYAO Somatostatin Sales Market Share (2011-2016)
Table ShuangCheng Basic Information List
Table ShuangCheng Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table ShuangCheng Somatostatin Sales Market Share (2011-2016)
Table TianTaiShan Basic Information List
Table TianTaiShan Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table TianTaiShan Somatostatin Sales Market Share (2011-2016)
Table Hainan Zhonghe Basic Information List
Table Hainan Zhonghe Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hainan Zhonghe Somatostatin Sales Market Share (2011-2016)
Table SL PHARM Basic Information List
Table SL PHARM Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table SL PHARM Somatostatin Sales Market Share (2011-2016)
Table Wuhan Hualon Basic Information List
Table Wuhan Hualon Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Wuhan Hualon Somatostatin Sales Market Share (2011-2016)
Table Qingdao Guoda Basic Information List
Table Qingdao Guoda Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qingdao Guoda Somatostatin Sales Market Share (2011-2016)
Table Chengdu Shengnuo Basic Information List
Table Chengdu Shengnuo Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chengdu Shengnuo Somatostatin Sales Market Share (2011-2016)
Table Longjin Basic Information List
Table Longjin Somatostatin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Longjin Somatostatin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Somatostatin
Figure Manufacturing Process Analysis of Somatostatin
Figure Somatostatin Industrial Chain Analysis
Table Raw Materials Sources of Somatostatin Major Manufacturers in 2015
Table Major Buyers of Somatostatin
Table Distributors/Traders List
Figure United States Somatostatin Production and Growth Rate Forecast (2016-2021)
Figure United States Somatostatin Revenue and Growth Rate Forecast (2016-2021)
Table United States Somatostatin Production Forecast by Type (2016-2021)
Table United States Somatostatin Consumption Forecast by Application (2016-2021)